Report Detail

Pharma & Healthcare Global Platinum-based Anticancer Drugs Market Outlook 2021

  • RnM4274578
  • |
  • 30 December, 2020
  • |
  • Global
  • |
  • 123 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Platinum-based Anticancer Drugs Market Overview

  • 1.1 Product Overview and Scope of Platinum-based Anticancer Drugs
  • 1.2 Platinum-based Anticancer Drugs Segment by Type
    • 1.2.1 Global Platinum-based Anticancer Drugs Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 Cisplatin
    • 1.2.3 Carboplatin
    • 1.2.4 Oxaliplatin
    • 1.2.5 Nedaplatin
    • 1.2.6 Others
  • 1.3 Platinum-based Anticancer Drugs Segment by Application
    • 1.3.1 Platinum-based Anticancer Drugs Sales Comparison by Application: (2020-2026)
    • 1.3.2 Testicular Cancer
    • 1.3.3 Osteosarcoma
    • 1.3.4 Breast Cancer
    • 1.3.5 Esophageal Cancer
    • 1.3.6 NSCLC
    • 1.3.7 Other
  • 1.4 Global Platinum-based Anticancer Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Platinum-based Anticancer Drugs Revenue 2015-2026
    • 1.4.2 Global Platinum-based Anticancer Drugs Sales 2015-2026
    • 1.4.3 Platinum-based Anticancer Drugs Market Size by Region: 2020 Versus 2026

2 Global Platinum-based Anticancer Drugs Market Competition by Manufacturers

  • 2.1 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Platinum-based Anticancer Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Platinum-based Anticancer Drugs Market Competitive Situation and Trends
    • 2.5.1 Platinum-based Anticancer Drugs Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Platinum-based Anticancer Drugs Players (Opinion Leaders)

3 Platinum-based Anticancer Drugs Retrospective Market Scenario by Region

  • 3.1 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.3.1 North America Platinum-based Anticancer Drugs Sales by Country
    • 3.3.2 North America Platinum-based Anticancer Drugs Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Platinum-based Anticancer Drugs Sales by Country
    • 3.4.2 Europe Platinum-based Anticancer Drugs Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Platinum-based Anticancer Drugs Sales by Region
    • 3.5.2 Asia Pacific Platinum-based Anticancer Drugs Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Platinum-based Anticancer Drugs Sales by Country
    • 3.6.2 Latin America Platinum-based Anticancer Drugs Sales by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country
    • 3.7.2 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Platinum-based Anticancer Drugs Historic Market Analysis by Type

  • 4.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2015-2020)
  • 4.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2015-2020)
  • 4.3 Global Platinum-based Anticancer Drugs Price Market Share by Type (2015-2020)
  • 4.4 Global Platinum-based Anticancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Platinum-based Anticancer Drugs Historic Market Analysis by Application

  • 5.1 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2015-2020)
  • 5.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2015-2020)
  • 5.3 Global Platinum-based Anticancer Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Platinum-based Anticancer Drugs Business

  • 6.1 Sanofi-Aventis
    • 6.1.1 Corporation Information
    • 6.1.2 Sanofi-Aventis Description, Business Overview
    • 6.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 Sanofi-Aventis Products Offered
    • 6.1.5 Sanofi-Aventis Recent Development
  • 6.2 Yakult honsha
    • 6.2.1 Yakult honsha Corporation Information
    • 6.2.2 Yakult honsha Description, Business Overview
    • 6.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 Yakult honsha Products Offered
    • 6.2.5 Yakult honsha Recent Development
  • 6.3 Dr Reddy's laboratories
    • 6.3.1 Dr Reddy's laboratories Corporation Information
    • 6.3.2 Dr Reddy's laboratories Description, Business Overview
    • 6.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Dr Reddy's laboratories Products Offered
    • 6.3.5 Dr Reddy's laboratories Recent Development
  • 6.4 Sun Pharmaceutical
    • 6.4.1 Sun Pharmaceutical Corporation Information
    • 6.4.2 Sun Pharmaceutical Description, Business Overview
    • 6.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Sun Pharmaceutical Products Offered
    • 6.4.5 Sun Pharmaceutical Recent Development
  • 6.5 Teva
    • 6.5.1 Teva Corporation Information
    • 6.5.2 Teva Description, Business Overview
    • 6.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Teva Products Offered
    • 6.5.5 Teva Recent Development
  • 6.6 Fresenius Kabi
    • 6.6.1 Fresenius Kabi Corporation Information
    • 6.6.2 Fresenius Kabi Description, Business Overview
    • 6.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 Fresenius Kabi Products Offered
    • 6.6.5 Fresenius Kabi Recent Development
  • 6.7 Hospira(Pfizer)
    • 6.6.1 Hospira(Pfizer) Corporation Information
    • 6.6.2 Hospira(Pfizer) Description, Business Overview
    • 6.6.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Hospira(Pfizer) Products Offered
    • 6.7.5 Hospira(Pfizer) Recent Development
  • 6.8 Mylan
    • 6.8.1 Mylan Corporation Information
    • 6.8.2 Mylan Description, Business Overview
    • 6.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 Mylan Products Offered
    • 6.8.5 Mylan Recent Development
  • 6.9 Taj Pharmaceuticals
    • 6.9.1 Taj Pharmaceuticals Corporation Information
    • 6.9.2 Taj Pharmaceuticals Description, Business Overview
    • 6.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.9.4 Taj Pharmaceuticals Products Offered
    • 6.9.5 Taj Pharmaceuticals Recent Development
  • 6.10 Jiangsu Hengrui Medicine
    • 6.10.1 Jiangsu Hengrui Medicine Corporation Information
    • 6.10.2 Jiangsu Hengrui Medicine Description, Business Overview
    • 6.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.10.4 Jiangsu Hengrui Medicine Products Offered
    • 6.10.5 Jiangsu Hengrui Medicine Recent Development
  • 6.11 Nanjing Pharmaceutical Factory
    • 6.11.1 Nanjing Pharmaceutical Factory Corporation Information
    • 6.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Description, Business Overview
    • 6.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.11.4 Nanjing Pharmaceutical Factory Products Offered
    • 6.11.5 Nanjing Pharmaceutical Factory Recent Development
  • 6.12 Jiangsu Aosaikang Pharmaceutical
    • 6.12.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
    • 6.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Description, Business Overview
    • 6.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.12.4 Jiangsu Aosaikang Pharmaceutical Products Offered
    • 6.12.5 Jiangsu Aosaikang Pharmaceutical Recent Development
  • 6.13 Qilu Pharmaceutical
    • 6.13.1 Qilu Pharmaceutical Corporation Information
    • 6.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Description, Business Overview
    • 6.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.13.4 Qilu Pharmaceutical Products Offered
    • 6.13.5 Qilu Pharmaceutical Recent Development
  • 6.14 Hisun Pharmaceutical
    • 6.14.1 Hisun Pharmaceutical Corporation Information
    • 6.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Description, Business Overview
    • 6.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.14.4 Hisun Pharmaceutical Products Offered
    • 6.14.5 Hisun Pharmaceutical Recent Development
  • 6.15 Luoxin
    • 6.15.1 Luoxin Corporation Information
    • 6.15.2 Luoxin Platinum-based Anticancer Drugs Description, Business Overview
    • 6.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.15.4 Luoxin Products Offered
    • 6.15.5 Luoxin Recent Development
  • 6.16 Lingnan Pharmacy
    • 6.16.1 Lingnan Pharmacy Corporation Information
    • 6.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Description, Business Overview
    • 6.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.16.4 Lingnan Pharmacy Products Offered
    • 6.16.5 Lingnan Pharmacy Recent Development
  • 6.17 Hansoh Pharma
    • 6.17.1 Hansoh Pharma Corporation Information
    • 6.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Description, Business Overview
    • 6.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
    • 6.17.4 Hansoh Pharma Products Offered
    • 6.17.5 Hansoh Pharma Recent Development

7 Platinum-based Anticancer Drugs Manufacturing Cost Analysis

  • 7.1 Platinum-based Anticancer Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Platinum-based Anticancer Drugs
  • 7.4 Platinum-based Anticancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Platinum-based Anticancer Drugs Distributors List
  • 8.3 Platinum-based Anticancer Drugs Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Platinum-based Anticancer Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Type (2021-2026)
  • 10.2 Platinum-based Anticancer Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Application (2021-2026)
  • 10.3 Platinum-based Anticancer Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Region (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Platinum-based Anticancer Drugs market is segmented into
    Cisplatin
    Carboplatin
    Oxaliplatin
    Nedaplatin
    Others

    Segment by Application
    Testicular Cancer
    Osteosarcoma
    Breast Cancer
    Esophageal Cancer
    NSCLC
    Other

    Global Platinum-based Anticancer Drugs Market: Regional Analysis
    The Platinum-based Anticancer Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Platinum-based Anticancer Drugs market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global Platinum-based Anticancer Drugs Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Platinum-based Anticancer Drugs market include:
    Sanofi-Aventis
    Yakult honsha
    Dr Reddy's laboratories
    Sun Pharmaceutical
    Teva
    Fresenius Kabi
    Hospira(Pfizer)
    Mylan
    Taj Pharmaceuticals
    Jiangsu Hengrui Medicine
    Nanjing Pharmaceutical Factory
    Jiangsu Aosaikang Pharmaceutical
    Qilu Pharmaceutical
    Hisun Pharmaceutical
    Luoxin
    Lingnan Pharmacy
    Hansoh Pharma


    Summary:
    Get latest Market Research Reports on Platinum-based Anticancer Drugs. Industry analysis & Market Report on Platinum-based Anticancer Drugs is a syndicated market report, published as Global Platinum-based Anticancer Drugs Market Outlook 2021. It is complete Research Study and Industry Analysis of Platinum-based Anticancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,120.36
    3,180.54
    4,240.72
    2,382.67
    3,574.00
    4,765.33
    301,008.40
    451,512.60
    602,016.80
    211,742.05
    317,613.08
    423,484.10
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report